Detalhe da pesquisa
1.
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Blood
; 137(25): 3473-3483, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33754642
2.
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 2024 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38295150
3.
Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics.
CPT Pharmacometrics Syst Pharmacol
; 10(4): 291-308, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33715307
4.
Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.
Cancer Res
; 80(3): 561-575, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31685543
5.
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor.
EMBO Mol Med
; 12(2): e9910, 2020 02 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31930715
6.
CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128.
Oncotarget
; 9(40): 26032-26045, 2018 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29899840
7.
Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplant.
CPT Pharmacometrics Syst Pharmacol
; 7(11): 748-758, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30343510
8.
Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug-Drug Interaction Studies?
Clin Pharmacol Ther
; 112(3): 453-455, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35687738
9.
Pharmacogenomics of statins: understanding susceptibility to adverse effects.
Pharmgenomics Pers Med
; 9: 97-106, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27757045
10.
GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.
Cell Metab
; 21(4): 622-7, 2015 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-25863251